News by Subject Medicine & Health

A global multidisciplinary group of HIV experts led by CUNY SPH Senior Scholar Jeffrey Lazarus and including Distinguished Professor Denis Nash and Associate Professor Diana Romero developed a consensus statement identifying the key issues health systems must address in order to move beyond the longtime emphasis on viral suppression to instead deliver integrated, person-centered healthcare for people living with HIV throughout their lives.

Adolescent girls and young women can and will use HIV prevention products with consistency, according to interim results of a study being conducted in Africa of two different methods: daily use of the antiretroviral (ARV) tablet Truvada® as oral pre-exposure prophylaxis (PrEP) and the monthly dapivirine vaginal ring, a new HIV prevention product currently under regulatory review in several countries. This was not been the case in previous trials of either approach.

The murders of George Floyd and other Black Americans have prompted a national outcry against structural racism and police brutality. How are leading nursing organizations and schools of nursing defining their positions on racism? That's the topic of a special article in the July/August issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Higher levels of plaque in people with HIV can be partly traced to the nontraditional risk factors of increased arterial inflammation and immune system activation. Researchers uncovered two key biomarkers of plaque that will be studied in the next phase of the global REPRIEVE trial to predict coronary plaque progression and major cardiovascular events, such as heart attacks and stroke, and the potential effects of statins.

A prospective cohort study found that treatment at an infusion center (IC) is associated with substantially better outcomes than treatment in the emergency department (ED) for patients with sickle cell disease (SCD) and uncomplicated vaso-occlusive crises. The findings are published in Annals of Internal Medicine.

Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18. The study was published in PLOS ONE in May 2021. The researchers would like to see this study have an impact on public health policy as well as the frequency of HIV screening in emergency departments across the country.

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that findings from a sub-study of REPRIEVE (A5332/A5332s, an international clinical trial studying heart disease prevention in people living with HIV) have been published in the Journal of the American Medical Association Network Open. The study found that approximately half of study participants, who were considered by traditional measures to be at low-to-moderate risk of future heart disease, had atherosclerotic plaque in their coronary arteries.

A new study by researchers at Penn State College of Medicine indicates that people living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) -- approximately 38 million worldwide -- are more likely to have suicidal thoughts and die from suicide than members of the general population.

New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional cure. Wistar scientists have identified metabolic and glycomic signatures in the blood of a rare population of HIV-infected individuals who can naturally sustain viral suppression after ART cessation, known as post-treatment controllers.